Mow Jonathan P

CIK 00013139421 companyMALVERN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001313942

Recent Transactions

33 trades

Award
PhaseBio Pharmaceuticals Inc
Common Stock
2022-05-20$0.68/sh+10,918→ 132,502 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2022-02-24+385,000→ 385,000 total
Award
PhaseBio Pharmaceuticals Inc
Restricted Stock Unit
2022-02-24+82,500→ 82,500 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2021-11-19$2.01/sh+5,623→ 172,473 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2021-11-03$1.24/sh−20,000→ 108,767 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2021-11-03$1.24/sh+20,000→ 166,850 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2021-08-27−20,000→ 128,767 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2021-08-27$1.24/sh+20,000→ 146,850 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2021-05-20$2.80/sh+3,964→ 126,850 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2021-02-05+234,000→ 234,000 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2020-11-20$3.00/sh+3,643→ 122,886 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2020-08-21−10,000→ 148,767 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2020-08-21$1.24/sh+10,000→ 119,243 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2020-02-12+290,000→ 290,000 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2019-09-06−19,000→ 158,767 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2019-09-06$1.24/sh+19,000→ 109,243 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2019-05-20$1.24/sh+19,131→ 90,243 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee stock option (right to buy)
2019-05-20−19,131→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2019-05-17$2.27/sh+19,913→ 71,112 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee stock option (right to buy)
2019-05-17−19,913→ 0 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2019-02-27+263,000→ 263,000 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-12-13$3.69/sh+1,000→ 51,199 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-12-10$3.85/sh+800→ 50,199 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-12-10$3.85/sh+800→ 51,699 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-12-07$3.88/sh+2,200→ 50,899 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-12-07$3.89/sh+700→ 49,399 total
Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22−310→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
2018-10-22−310→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+3,505→ 48,699 total
Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22−3,505→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+310→ 310 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$0.12/sh+310→ 310 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2018-10-17+220,000→ 220,000 total

Companies

PhaseBio Pharmaceuticals Inc
Director, Chief Executive Officer

Recent Filings

Address

C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30

MALVERN, PA, 19355

View on SEC.gov